At a glance
ClinicalIndex Comparison RecordN/ACompleted· 749 enrolled
Drug / intervention
Re-Engineered Hospital Dischargebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Testing the Re-Engineered Hospital Discharge
In Brief
A clinical study evaluating Re-Engineered Hospital Discharge for All. Completed, enrolled 749 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if the "Re-Engineered Discharge" will decrease rehospitalization rates and adverse events of patients leaving Boston Medical Center.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAll
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 2005
Enrollment StartDec 2005
Primary CompletionOct 2007
TodayJul 2026
First PostedNov 11, 2005
Enrollment StartDec 1, 2005
Primary CompletionOct 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 20.6 years ago
Interventions
Re-Engineered Hospital Dischargebehavioral
The "Re-engineered Hospital Discharge" (Project RED) intervention provides a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call after discharge by a clinical pharmacist.